Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Hiroo Takayama, MD, PhD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colarodo
Aurora, Colorado, United States
- Minneapolis Heart Institute
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Newark Beth Israel Medical Center
Newark, New Jersey, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Westchester Medical Center
Valhalla, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2013
- Primary completion
- 11 Feb 2020
- Completion
- 11 Feb 2020
- Last update posted
- 13 Apr 2023
- Registered enrollment
- 1,089
- Registry id
- NCT02790242
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.